Fibrinogen and P-selectin expression in atherosclerosis model of Sprague Dawley rat

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3768-3772

  Zhou, Bi Rong ^a   Pan, Ying ^a   Zhai, Zhi Min ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Fibrinogen; P selectin

Indexed keywords

ERGOCALCIFEROL; FIBRINOGEN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CELL SURFACE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; FLOW CYTOMETRY; FOAM CELL; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIPID DIET; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; THROMBOCYTE;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PLATELETS; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; P-SELECTIN; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 82255195481     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.030     Document Type: Article

References (25)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
2. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666.
3. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
4. Hu MY. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition 2008; 24: 1030-1038.
5. George JN, Lyons RM, Morgan RK. Membrane changes associated with platelet activation. Exposure of action on the platelet surface after thrombin-induced secretion. J Clin Invest 1980; 66: 1-9.
6. Li Z, Delaney MK, O'Brien KA. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341-2349.
7. Yang H, Lang S, Zhai Z. Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression. Blood 2009; 114: 425-436.
8. Zhai Z, Wu J, Xu X, Ding K, Ni R, Hu W, et al. Fibrinogen controls human platelet fibronectin internalization and cell surface retention. J Thromb Haemostasis 2007; 5: 1740-1746.
9. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
10. Li X, Cong H. Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome. Tex Heart Inst J 2009; 36: 134-139.
11. Eriksson AC, Jonasson L, Lindahl TL, Hedbäck B, Whiss PA. Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study. J Transl Med 2009; 7: 42-56.
12. Tang Y, Yang Y, Wang S, Huang T, Tang C, Xu Z, Sun Y. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement. Chin Med J 2009; 122: 319-325.
13. de Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb Hemost 2010; 36: 7-17.
14. Green D, Foiles N, Chan C, Schreiner PJ, Liu K. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study. Atherosclerosis 2009; 202: 623-631.
15. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-756.
16. Luo J, Wu G, Xiong Y, Chen G, Xie Q, Yang D, et al. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia. Chin Med J 2009; 122: 1188-1194.
17. Nikolaos P, Dimitris T, Gerasimos S, Christodoulos S. Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic J Cardiol 2010; 51: 1-9.
18. Lin X, Zhu W, Tan L, Xu T, Xu R, Fang Q, et al. Gender specific association of neonatal characteristics and cardiovascular risk factors on carotid intima-media thickness in a Chinese cohort. Chin Med J 2010; 123: 2310-2314.
19. Ersan T, Fatih O, Meryem A. Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction. Cardiol J 2009; 16: 317-320.
20. Jing L, Gao P, Lin Y, Sui B, Qin H, Ma L, et al. Distribution of wall shear stress in carotid plaques using. Chin Med J 2011; 124: 1465-1469.
21. Thomas WJ, Ansgar JP, Gunnar P, Frank-Chris S. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes-a two year follow-up of 243 patients. Cardiovasc Diabetol 2009; 8: 48-58.
22. de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders. Semin Thromb Hemost 2009; 35: 356-366.
23. Schwertz H, Zimmerman GA, Weyrich AS. Fibrinogen selects selectins. Blood 2009; 114: 234.
24. Dong ZM, Brown AA, Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 2000; 101: 2290-2295.
25. Grebe MT, Luu B, Sedding D, Heidt MC, Kemkes-Matthes B, Schaefer CA, et al. Fibrinogen promotes early atherosclerotic changes of the carotid artery in young, healthy adults. J Atheroscler Thromb 2010; 17: 1003-1008.